120 related articles for article (PubMed ID: 1315325)
1. Comparison of an EBV transformed cell line and an EBV hybridoma cell line producing the same human anti-HBs monoclonal antibody.
Sa'adu A; Walker H; Locniskar M; Bidwell D; Howard C; McAdam KP; Voller A
J Virol Methods; 1992 Apr; 37(1):1-11. PubMed ID: 1315325
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of human anti-HBs antibodies.
Sa'adu A; Locniskar M; Bidwell D; Howard C; McAdam KP; Voller A
J Virol Methods; 1992 Jan; 36(1):25-34. PubMed ID: 1372611
[TBL] [Abstract][Full Text] [Related]
3. Production of anti-tumor human monoclonal antibodies using different approaches.
Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
[TBL] [Abstract][Full Text] [Related]
4. Establishment of human heterohybridoma and lymphoblastoid cell lines specific for the Rh D and C antigens.
Pasha RP; Roohi A; Shokri F
Transfus Med; 2003 Apr; 13(2):83-92. PubMed ID: 12694553
[TBL] [Abstract][Full Text] [Related]
5. Use of an enzyme-linked immunosorbent assay for screening hybridoma antibodies against hepatitis B surface antigen.
Boniolo A; Dovis M; Matteja R
J Immunol Methods; 1982; 49(1):1-15. PubMed ID: 7061870
[TBL] [Abstract][Full Text] [Related]
6. Establishment of hybridoma secreting human monoclonal antibody against hepatitis B virus surface antigen.
Ichimori Y; Harada K; Hitotsumachi S; Tsukamoto K
Biochem Biophys Res Commun; 1987 Feb; 142(3):805-12. PubMed ID: 3030301
[TBL] [Abstract][Full Text] [Related]
7. Generation of murine triomas secreting bi-specific monoclonal antibodies that recognize HBsAG ad and ay subtypes.
Falero G; Rodríguez I; Sarracent J; Otero AJ; Rodríguez BL; Rojas A; Ochoa E
Hybridoma; 1992 Dec; 11(6):815-23. PubMed ID: 1294458
[TBL] [Abstract][Full Text] [Related]
8. The effects of hybridoma growth factor in conditioned media upon the growth, cloning, and antibody production of heterohybridoma cell lines.
Zhu Y; Jin B; Sun C; Huang C; Liu X
Hum Antibodies Hybridomas; 1993 Jan; 4(1):31-5. PubMed ID: 8431556
[TBL] [Abstract][Full Text] [Related]
9. Characterization of mouse-human hybridoma as a useful fusion partner for the establishment of mouse-human-human hybridoma secreting anti-tetanus toxoid human monoclonal antibody of IgM or IgG class.
Hirata Y; Sugawara I
Microbiol Immunol; 1987; 31(3):231-45. PubMed ID: 3613992
[TBL] [Abstract][Full Text] [Related]
10. Human monoclonal antibody to purified protein derivative of tuberculin produced by hybrids constructed with Epstein-Barr virus-transformed B lymphocytes and mouse myeloma cells.
Garzelli C; Puglisi C; Falcone G
Eur J Immunol; 1986 May; 16(5):584-7. PubMed ID: 3009205
[TBL] [Abstract][Full Text] [Related]
11. Transgenic tobacco cells producing the human monoclonal antibody to hepatitis B virus surface antigen.
Yano A; Maeda F; Takekoshi M
J Med Virol; 2004 Jun; 73(2):208-15. PubMed ID: 15122794
[TBL] [Abstract][Full Text] [Related]
12. Antibody production of a human EBV-transformed B cell line and its heterohybridoma and trioma cell line descendants in different culture systems.
Gustafsson B; Hinkula J
Hum Antibodies Hybridomas; 1994; 5(3-4):98-104. PubMed ID: 7756584
[TBL] [Abstract][Full Text] [Related]
13. Generation of a human hybridoma producing a pure anti-HLA-A2 monoclonal antibody.
Wallace EF; Foung SK; Bradbury K; Pask SL; Grumet FC
Hum Immunol; 1990 May; 28(1):65-9. PubMed ID: 2160447
[TBL] [Abstract][Full Text] [Related]
14. Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma.
Foung SK; Perkins S; Raubitschek A; Larrick J; Lizak G; Fishwild D; Engleman EG; Grumet FC
J Immunol Methods; 1984 May; 70(1):83-90. PubMed ID: 6201562
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies to hepatitis B surface antigen: production and characterization.
Hlozánek I; Dostálová V; Korec E; Zelený V; König J; Nĕmecek V
Folia Biol (Praha); 1986; 32(3):167-77. PubMed ID: 3527770
[TBL] [Abstract][Full Text] [Related]
16. Selection of new heteromyeloma cell lines for the obtainment of human monoclonal antibodies.
Zanella I; Verardi R; Negrini R; Osio L; Albertini A; Ghielmi S
Year Immunol; 1993; 7():213-9. PubMed ID: 8396821
[No Abstract] [Full Text] [Related]
17. Stability of specific immunoglobulin secretion by EBV-transformed lymphoblastoid cells and human-murine heterohybridomas.
Glasky MS; Reading CL
Hybridoma; 1989 Aug; 8(4):377-89. PubMed ID: 2550358
[TBL] [Abstract][Full Text] [Related]
18. Production of human monoclonal IgG antibodies reacting with cytomegalovirus (CMV).
Bron D; Delforge A; Lagneaux L; De Martynoff G; Bosmans E; Van der Auwera P; Snoeck R; Burny A; Stryckmans P
J Immunol Methods; 1990 Jul; 130(2):209-16. PubMed ID: 2165098
[TBL] [Abstract][Full Text] [Related]
19. Characterization of stable Epstein-Barr (EB) virus transformed cell lines and mouse-human hybridomas producing a large quantity of anti-tetanus toxoid (TT) monoclonal antibody.
Minakawa H; Hirata Y; Sugawara I; Fukuda A; Yoshida TO
Behring Inst Mitt; 1985 Dec; (78):139-47. PubMed ID: 3008706
[TBL] [Abstract][Full Text] [Related]
20. Renewal of EBV-hybridoma method: efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells.
Ainai A; Kawase T; Ida A; Maeda Y; Ohba H; Ikeda Y; Sato H; Takahashi M; Chiba J
Hum Antibodies; 2006; 15(4):139-54. PubMed ID: 17522436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
